Alternatives to Onco Access

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Genomic data analysis platform for rare diseases and cancer.

Global life sciences company providing diagnostic and biopharma laboratory services.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered medical imaging analysis and diagnostic support for radiologists.

AI-driven clinical-grade breast cancer guide for women navigating their journey.

Data-driven software solutions for precision medicine and pharmaceutical development.

AI-powered breast cancer detection and risk assessment solutions.

Specialized services for pharmaceutical and life sciences clients across product development and commercialization.

Primary research platform connecting healthcare and life sciences knowledge seekers with subject matter experts.

Digital therapeutics for hematology and oncology, connecting doctors and patients to track and predict disease.

AI-powered digital platform for life sciences, accelerating clinical research and drug development.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered spatial biology platform for precision medicine and drug development.

Developing engineered biologics to harness the immune system for disease treatment.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Natera is a global leader in cell-free DNA testing, providing genetic testing services for reproductive health, oncology, and organ transplantation.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-powered clinical trial recruitment platform advancing health equity.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Verana Health is a data science company focused on real-world evidence for ophthalmology.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biotechnology company developing novel immunotherapies for cancer.

Biotechnology company developing potentially curative cell therapies for cancer patients.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Developing novel diagnostics to predict patient response to immunotherapy.

Digital pathology imaging technology and AI-driven precision pathology software.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

NantHealth provides a suite of healthcare solutions focused on precision medicine and data analytics.

Immunotherapy company targeting oncology and autoimmune diseases.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Clinical-stage immunotherapy company developing novel treatments for cancer.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Advancing targeted alpha therapies.

Developing a new histotripsy therapeutic platform for cancer treatment.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

Wearable devices and AI for continuous health monitoring and early disease detection.

Enabling pharmaceutical companies to deliver medications directly to patients at scale.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Healthcare analytics company making high-quality, affordable healthcare accessible through a data platform.

Smart homecare technology platform for agencies to streamline operations and improve care quality.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.